Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Steven D. Nathan, P Smith, C. Q. Deng, Christopher S. King et autres
3 citationsNew England Journal of Medicine
Murali Ramaswamy
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
48Publications signalées
1478Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related DiseasesChronic Obstructive Pulmonary Disease (COPD) ResearchPulmonary Hypertension Research and TreatmentsRespiratory viral infections research
Publications récentes
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
Alberto Papi, Neil Greening, Surya P Bhatt, N Roche et autres
15 citationsThe Lancet
Deupirfenidone compared with pirfenidone and placebo in idiopathic pulmonary fibrosis (ELEVATE-IPF): a phase 2b randomized placebo-controlled trial
Toby M Maher, Mark J. Hamblin, Won-II Choi, Amy Hajari Case et autres
3 citationsAmerican Journal of Respiratory and Critical Care Medicine
P91 Real-world healthcare resource utilization in patients with idiopathic pulmonary fibrosis initiating antifibrotic therapy in the medicare fee-for-service population
B Wu, Anthony F. Yu, Erin Roberts, Kellie Morland et autres
0 citations
CO131 Real-World Persistence to Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis in a Commercial and Medicare Advantage Population
Manisha Lin, Benjamin Wu, Kellie Morland, Murali Ramaswamy
0 citationsValue in Health
CO93 Real-World Healthcare Resource Utilization in Patients with Idiopathic Pulmonary Fibrosis initiating Antifibrotic Therapy in the Medicare Fee-For-Service Population
Benjamin Wu, Anthony Yu, Manisha Lin, Erin Roberts et autres
0 citationsValue in Health
Predictors of Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry
Hyun Joo Kim, Jeremy M. Weber, Megan L. Neely, Amy Hajari Case et autres
8 citationsLung
Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis
L.J. Lobo, Yi Liu, Peide Li, Murali Ramaswamy et autres
8 citationsBMC Pulmonary Medicine
HIGH SENSITIVITY OF A NASAL GENOMIC CLASSIFIER FOR IDENTIFYING MALIGNANT PULMONARY NODULES: A PRELIMINARY ANALYSIS
Bradley Icard, Murali Ramaswamy, ERIC MORRIE, Janna S. Chamberlin et autres
0 citationsCHEST Journal
Author response for "Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study"
Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim Wuyts et autres
0 citations
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial
Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim Wuyts et autres
73 citationsAmerican Journal of Respiratory and Critical Care Medicine
Pamrevlumab for Idiopathic Pulmonary Fibrosis
Ganesh Raghu, Luca Richeldi, Evans R. Fernández Pérez, María Cristina De Salvo et autres
79 citationsJAMA
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.